RZ358 (5 mg/kg) + SOC (Standard-of-Care) or Placebo + SOC clinical trials

RZ358 Treatment for Congenital Hyperinsulinism

This study is testing a new medicine, RZ358, for children and adults with congenital hyperinsulinism (CHI). This condition causes very low blood sugar. The study will see how well RZ358 works to control blood sugar and if it's safe, compared to current treatments alone.